David X. Medina
Affiliations: | Neurobiology | Barrow Neurological Institute, Phoenix, AZ, United States |
Google:
"David Medina"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bell L, Fuentes AE, Healey DR, et al. (2021) Longitudinal evaluation of myofiber microstructural changes in a preclinical ALS model using the transverse relaxivity at tracer equilibrium (TRATE): A preliminary study. Magnetic Resonance Imaging |
Medina DX, Chung EP, Teague CD, et al. (2020) Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1 Mouse Model of ALS. Frontiers in Bioengineering and Biotechnology. 8: 224 |
Medina DX, Chung EP, Bowser R, et al. (2019) Lipid and polymer blended polyester nanoparticles loaded with adapalene for activation of retinoid signaling in the CNS following intravenous administration Journal of Drug Delivery Science and Technology. 52: 927-933 |
Medina DX, Householder KT, Ceton R, et al. (2017) Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Caccamo A, Magrì A, Medina DX, et al. (2013) mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell. 12: 370-80 |
Caccamo A, Medina DX, Oddo S. (2013) Glucocorticoids exacerbate cognitive deficits in TDP-25 transgenic mice via a glutathione-mediated mechanism: implications for aging, stress and TDP-43 proteinopathies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 906-13 |
Caccamo A, Maldonado MA, Majumder S, et al. (2011) Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. The Journal of Biological Chemistry. 286: 8924-32 |